BioLargo, Inc. (BLGO)
OTCMKTS
· Delayed Price · Currency is USD
0.2300
-0.0020 (-0.86%)
Apr 17, 2025, 4:00 PM EDT
BioLargo Revenue
In the year 2024, BioLargo had annual revenue of $17.78M with 45.37% growth. BioLargo had revenue of $3.66M in the quarter ending December 31, 2024, a decrease of -16.32%.
Revenue
17.78M
Revenue Growth
+45.37%
P/S Ratio
3.93
Revenue / Employee
423.31K
Employees
44
Market Cap
69.90M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
Dec 31, 2020 | 2.43M | 571.00K | 30.68% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Monarch Cement Company | 268.05M |
Rubber Leaf | 6.93M |
Cardinal Ethanol, LLC | 350.34M |
Venator Materials | 1.56B |
Verde Resources | 216.80K |
Webco Industries | 575.71M |
BioLargo News
- 15 days ago - BioLargo to Present at the LD Micro Invitational XV - Newsfile Corp
- 18 days ago - Cleantech Innovator BioLargo Reports Record Revenues in 2024 Annual Report - Accesswire
- 18 days ago - BioLargo to Present at the AI & Technology Virtual Investor Conference April 3, 2025 - GlobeNewsWire
- 18 days ago - BioLargo, Inc. (BLGO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - BioLargo Year-End 2024 Earnings Results Webcast and Conference Call on Monday, March 31, 2025 - 4:00 PM Eastern Time - Accesswire
- 5 weeks ago - BioLargo Invited to Showcase PFAS Treatment Technology at Industry Leading Water Conference - Accesswire
- 3 months ago - BioLargo Provides 2024 Review and 2025 Outlook - Accesswire
- 3 months ago - BioLargo Provides 2024 Review and 2025 Outlook - Accesswire